These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 21255693)

  • 1. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.
    McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ
    Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation.
    Dudakovic A; Evans JM; Li Y; Middha S; McGee-Lawrence ME; van Wijnen AJ; Westendorf JJ
    J Biol Chem; 2013 Oct; 288(40):28783-91. PubMed ID: 23940046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitors promote osteoblast maturation.
    Schroeder TM; Westendorf JJ
    J Bone Miner Res; 2005 Dec; 20(12):2254-63. PubMed ID: 16294278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to vorinostat induced bone loss in mice.
    McGee-Lawrence ME; Westendorf JJ
    Bone; 2013 Dec; 57(2):531-2. PubMed ID: 23973558
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.
    Xu S; De Veirman K; Evans H; Santini GC; Vande Broek I; Leleu X; De Becker A; Van Camp B; Croucher P; Vanderkerken K; Van Riet I
    Acta Pharmacol Sin; 2013 May; 34(5):699-709. PubMed ID: 23564084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats.
    Gilmour PS; O'Shea PJ; Fagura M; Pilling JE; Sanganee H; Wada H; Courtney PF; Kavanagh S; Hall PA; Escott KJ
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):399-407. PubMed ID: 23872097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL.
    Kim HN; Ha H; Lee JH; Jung K; Yang D; Woo KM; Lee ZH
    Eur J Pharmacol; 2009 Nov; 623(1-3):22-9. PubMed ID: 19766111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
    Zhou Q; Dalgard CL; Wynder C; Doughty ML
    BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of suberoylanilide hydroxamic acid against LPS-induced septic shock in rodents.
    Li Y; Liu B; Zhao H; Sailhamer EA; Fukudome EY; Zhang X; Kheirbek T; Finkelstein RA; Velmahos GC; deMoya M; Hales CA; Alam HB
    Shock; 2009 Nov; 32(5):517-23. PubMed ID: 19295477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-bone-mass phenotype of deficient mice for the cluster of differentiation 36 (CD36).
    Kevorkova O; Martineau C; Martin-Falstrault L; Sanchez-Dardon J; Brissette L; Moreau R
    PLoS One; 2013; 8(10):e77701. PubMed ID: 24204923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.
    Shankar S; Davis R; Singh KP; Kurzrock R; Ross DD; Srivastava RK
    Mol Cancer Ther; 2009 Jun; 8(6):1596-605. PubMed ID: 19509267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells.
    Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A
    Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of bone sialoprotein (BSP) impairs primary bone formation and resorption: the marrow ablation model under PTH challenge.
    Wade-Gueye NM; Boudiffa M; Vanden-Bossche A; Laroche N; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
    Bone; 2012 May; 50(5):1064-73. PubMed ID: 22586700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity.
    Negmeldin AT; Knoff JR; Pflum MKH
    Eur J Med Chem; 2018 Jan; 143():1790-1806. PubMed ID: 29150330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid.
    Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN
    J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic reprogramming enhances the therapeutic efficacy of osteoblast-derived extracellular vesicles to promote human bone marrow stem cell osteogenic differentiation.
    Man K; Brunet MY; Fernandez-Rhodes M; Williams S; Heaney LM; Gethings LA; Federici A; Davies OG; Hoey D; Cox SC
    J Extracell Vesicles; 2021 Jul; 10(9):e12118. PubMed ID: 34262674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide affects bone remodeling by effects on osteoblast differentiation and function.
    Hu YC; Cheng HL; Hsieh BS; Huang LW; Huang TC; Chang KL
    Bone; 2012 Jun; 50(6):1406-15. PubMed ID: 22465848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Osteogenic Activity of Suberoylanilide Hydroxamic Acid is Synergized by BMP-2.
    Lee ZH; Kim HJ; Ryoo HM
    J Bone Metab; 2015 May; 22(2):51-6. PubMed ID: 26082914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo.
    Syberg S; Brandao-Burch A; Patel JJ; Hajjawi M; Arnett TR; Schwarz P; Jorgensen NR; Orriss IR
    J Bone Miner Res; 2012 Nov; 27(11):2373-86. PubMed ID: 22714653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular sequelae of histone deacetylase inhibition in human malignant B cells.
    Mitsiades N; Mitsiades CS; Richardson PG; McMullan C; Poulaki V; Fanourakis G; Schlossman R; Chauhan D; Munshi NC; Hideshima T; Richon VM; Marks PA; Anderson KC
    Blood; 2003 May; 101(10):4055-62. PubMed ID: 12531799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.